HALO NASDAQ · Healthcare · FY 2025-12-31

HALOZYME THERAPEUTICS, INC.

0.022.344.666.989.1ABVnot valid for this companyEPVfair 42.31buy ≤ 27.50EBVfair 4.89buy ≤ 2.69DBVnot valid for this companyprice 82.54 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Asset-Light Compounder
Confidence
●●○ Medium · 2/4

Price
82.540 USD
Market cap
9.72B USD
P / B
199.16
P / E
32.24
EPS
2.560
DPS / yield
(0.0%)
NAV / share
-12.846
Graham number
4.886
Z'' score
3.07
Piotroski F
5 / 9
Beneish M
-2.58
ROIC vs WACC
16.0% vs 8.2%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.